Boston Scientific Inches Closer To A Breakout After Eking Out A Third-Quarter BeatInvestors Business Daily • 10/26/23
Boston Scientific beats quarterly profit estimates on strength in heart devices unitReuters • 10/26/23
Boston Scientific AGENT™ Drug-Coated Balloon Demonstrates Superiority to Uncoated Balloon Angioplasty in the AGENT IDE TrialPRNewsWire • 10/25/23
REAL-PE Study Demonstrates Statistically Significant Lower Major Bleeding Rates with the EKOS™ Endovascular System Compared to Mechanical Thrombectomy Device for Treatment of Pulmonary EmbolismPRNewsWire • 10/24/23
Boston Scientific Announces Conference Call Discussing Third Quarter 2023 ResultsPRNewsWire • 10/02/23
Boston Scientific Briefly Launches Into Buy Zone, But Investor Day Hype CoolsInvestors Business Daily • 09/20/23
Boston Scientific to acquire Relievant Medsystems for $850 million upfront, plus milestone paymentsMarket Watch • 09/19/23